Heart Disease Is Largest Driver Of Health Costs – Health Affairs Study
This article was originally published in The Tan Sheet
Executive Summary
Chronic heart conditions accounted for an estimated 8% of the increase in total health spending from 1987 to 2000, according to a health economics study published in the Aug. 25 Health Affairs
You may also be interested in...
J&J/Merck Developing Mevacor 20 Mg As OTC For Moderate Risk Group
J&J/Merck's second try at an Rx-to-OTC switch for Mevacor (lovastatin) involves a 20 mg dose targeted at a moderate to intermediate risk group, according to VP-Regulatory & Scientific Affairs Edwin Hemwall, PhD
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands